These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3473174)

  • 1. Concentrations of progesterone and oestradiol-17 beta after administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to sheep in late pregnancy.
    Taylor MJ
    J Endocrinol; 1987 Apr; 113(1):97-101. PubMed ID: 3473174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on maternal and fetal steroid concentrations of induction of parturition in the sheep by inhibition of 3 beta-hydroxysteroid dehydrogenase.
    Silver M
    J Reprod Fertil; 1988 Mar; 82(2):457-65. PubMed ID: 2834551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an inhibitor of 3 beta-hydroxysteroid dehydrogenase on progesterone concentrations and embryo survival in sheep.
    Ashworth CJ; Wilmut I; Springbett AJ; Webb R
    J Endocrinol; 1987 Feb; 112(2):205-13. PubMed ID: 3469294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolytic action of RU486: modulation of luteal 3 beta-hydroxysteroid dehydrogenase and 20 alpha-hydroxysteroid dehydrogenase activities in late pregnant rats.
    Tellería CM; Stocco CO; Deis RP
    J Steroid Biochem Mol Biol; 1995 Jun; 52(6):567-73. PubMed ID: 7779760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the concentrations of plasma steroid hormone and plasma 13, 14-dihydro-15-oxo-prostaglandin F2 alpha in late pregnancy rabbits treated with an inhibitor of 3 beta-hydroxysteroid dehydrogenase.
    Makimura N; Kato K; Seki K; Mitsui C
    Endocrinol Jpn; 1984 Jun; 31(3):349-53. PubMed ID: 6594231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of progesterone secretion by a 3 beta-hydroxysteroid dehydrogenase inhibitor in late pregnant sheep.
    Jenkin G; Thorburn GD
    Can J Physiol Pharmacol; 1985 Feb; 63(2):136-42. PubMed ID: 3857102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of labour in sheep by inhibition of 3-beta hydroxysteroid dehydrogenase: role of the fetal adrenal.
    Silver M; Fowden AL
    J Dev Physiol; 1991 Mar; 15(3):169-74. PubMed ID: 1658115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 3 beta-hydroxysteroid dehydrogenase in the sow near term: effects on fetal and maternal steroids and on delivery.
    Silver M; Fowden AL
    Q J Exp Physiol; 1988 Jan; 73(1):67-78. PubMed ID: 3162325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of epostane, a 3-beta hydroxy steroid dehydrogenase inhibitor, on maternal and fetal steroid levels during mid-gestation.
    Selinger M; MacKenzie IZ; Gillmer MD; Phipps SL; Ferguson J
    Br J Obstet Gynaecol; 1988 Jun; 95(6):596-601. PubMed ID: 3291938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of progesterone secretion by a 3 beta-hydroxysteroid dehydrogenase inhibitor in pregnant goats.
    Taylor MJ
    J Endocrinol; 1987 Jun; 113(3):489-93. PubMed ID: 3625098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhibition of prostaglandin synthesis on cervical softening and uterine activity during ovine parturition resulting from progesterone withdrawal induced by epostane.
    Ledger WL; Webster MA; Anderson AB; Turnbull AC
    J Endocrinol; 1985 May; 105(2):227-33. PubMed ID: 3857291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of parturition in swine and epostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase.
    Martin PA; Hammitt DG; Strohbehn RS; Keister DM
    J Anim Sci; 1987 Feb; 64(2):497-506. PubMed ID: 3470276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhibiting 3 beta-hydroxysteroid dehydrogenase on plasma progesterone and other steroids in the pregnant mare near term.
    Fowden AL; Silver M
    J Reprod Fertil Suppl; 1987; 35():539-45. PubMed ID: 3479607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of preovulatory gonadotrophin surges by epostane: a new inhibitor of 3 beta-hydroxysteroid dehydrogenase.
    DePaolo LV
    J Endocrinol; 1988 Jul; 118(1):59-68. PubMed ID: 3137304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of early pregnancy by the 3 beta-hydroxysteroid dehydrogenase inhibitor epostane.
    Crooij MJ; de Nooyer CC; Rao BR; Berends GT; Gooren LJ; Janssens J
    N Engl J Med; 1988 Sep; 319(13):813-7. PubMed ID: 3166108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing ovulation rate and lambing rate in sheep by treatment with a steroid enzyme inhibitor.
    Webb R
    J Reprod Fertil; 1987 Jan; 79(1):231-40. PubMed ID: 3820174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteolytic effect of LH: inhibition of 3 beta-hydroxysteroid dehydrogenase and stimulation of 20 alpha-hydroxysteroid dehydrogenase luteal activities in late pregnant rats.
    Stocco CO; Deis RP
    J Endocrinol; 1996 Sep; 150(3):423-9. PubMed ID: 8882161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myometrial activity in first trimester human pregnancy after Epostane therapy. Effect of intravenous oxytocin.
    Webster MA; Pattison NS; Phipps SL; Gillmer MD
    Br J Obstet Gynaecol; 1985 Sep; 92(9):957-62. PubMed ID: 3862426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone withdrawal without parturition.
    Mitchell MD; Brennecke SP; Kraemer DL; Webb R
    Eur J Obstet Gynecol Reprod Biol; 1983 Apr; 15(1):25-30. PubMed ID: 6884563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of transient functional luteolysis in cyclic sheep by a 3 beta-hydroxysteroid dehydrogenase inhibitor.
    Jenkin G; Gemmell RT; Thorburn GD
    J Endocrinol; 1984 Jan; 100(1):61-6. PubMed ID: 6581254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.